Hepatitis
B is highly prevalent among Asians and Asian-Americans, but hepatitis
C in this population is less well characterized.
As
described in the December 2006 American Journal of Gastroenterology, researchers
conducted a retrospective survey to assess the demographics, epidemiology, and
natural history of chronic hepatitis C in Asian-Americans. The study included
260 Asian-American chronic HCV patients referred to a single tertiary center in
California.
Results
92% percent of the
study participants were born in Asia.
51%
reported a history of unsafe therapeutic injections.
Unsafe injection was a risk factor only for those with HCV exposure outside the
United States.
41%
reported a history of blood transfusion, which was more frequent among those with
exposure within the Unites States.
Only 3.8% reported a history of injection
drug abuse, which was more frequent among those with exposure within the United
States.
A logistic regression
model revealed that the following factors predicted development of HCC:
-
fibrosis stage 4 (OR 8.87); - older age at presentation (55 vs 35 years: OR
3.45); - baseline albumin level (3.0 vs 4.0 mg/dL: OR 3.47).
Conclusion
"Asian-Americans
with a history of unsafe therapeutic injections must be screened for chronic hepatitis
C," the authors recommended. "Antiviral treatment should be initiated
prior to development of cirrhosis. Surveillance for HCC must be routinely performed
in cirrhosis patients."
01/30/07
Reference J
T Cheng, C Hsien, H E Sun, and others. The emerging importance of chronic hepatitis
C infection in Asian Americans. American Journal of Gastroenterology 101(12):
2737-2743. December 2006.